Literature DB >> 4785284

Plasma and urinary zinc in patients with malabsorption syndromes or hepatic cirrhosis.

B E Walker, J B Dawson, J Kelleher, M S Losowsky.   

Abstract

Plasma and urinary zinc have been measured in 19 patients with malabsorption and 21 patients with hepatic cirrhosis. The results have been compared with those of 20 control subjects and 23 patients with a variety of other diseases. The diurnal variation in plasma zinc levels has been confirmed and is of such magnitude that this must be taken into account in comparing results in groups of subjects. Plasma zinc levels, both fasting and after a meal, are significantly lower in patients with cirrhosis (71 and 60 mug/100 ml) and malabsorption (76 and 64 mug/100 ml) than in controls (97 and 81 mug/100 ml). In the patients with cirrhosis or malabsorption similar correlations exist between plasma zinc and plasma albumin, suggesting that the low plasma zinc levels may be, at least in part, dependent on the plasma albumin level. Urinary zinc excretion is increased in cirrhosis, but not in malabsorption, indicating that increased urinary loss is unlikely to explain the low plasma levels.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4785284      PMCID: PMC1412860          DOI: 10.1136/gut.14.12.943

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Zinc in human blood cells: normal values and abnormalities associated with liver disease.

Authors:  R E FREDRICKS; K R TANAKA; W N VALENTINE
Journal:  J Clin Invest       Date:  1960-11       Impact factor: 14.808

2.  Zinc metabolism in hepatic dysfunction. II. Correlation of metabolic patterns with biochemical findings.

Authors:  B L VALLEE; W E WACKER; A F BARTHOLOMAY; F L HOCH
Journal:  N Engl J Med       Date:  1957-11-28       Impact factor: 91.245

3.  Studies on zinc in blood II.

Authors:  I VIKBLADH
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

4.  Plasma-zinc concentrations in patients with psoriasis, other dermatoses, and venous leg ulceration.

Authors:  M Greaves; T R Boyde
Journal:  Lancet       Date:  1967-11-11       Impact factor: 79.321

5.  Plasma-zinc in psoriasis.

Authors:  A F Withers; H Baker; M Musa; T L Dormandy
Journal:  Lancet       Date:  1968-08-03       Impact factor: 79.321

Review 6.  Significance of magnesium and zinc metabolism in the surgical patient. II. Zinc.

Authors:  J H Henzel; M S DeWeese; W J Pories
Journal:  Arch Surg       Date:  1967-12

7.  Direct determination of zinc in whole blood, plasma and urine by atomic absorption spectroscopy.

Authors:  J B Dawson; B E Walker
Journal:  Clin Chim Acta       Date:  1969-12       Impact factor: 3.786

8.  Urine and serum zinc abnormalities in disease of the liver.

Authors:  A M Kahn; H L Helwig; A G Redeker; T B Reynolds
Journal:  Am J Clin Pathol       Date:  1965-10       Impact factor: 2.493

9.  Measurements of plasma zinc. II. In malignant disease.

Authors:  I J Davies; M Musa; T L Dormandy
Journal:  J Clin Pathol       Date:  1968-05       Impact factor: 3.411

10.  SERUM ALBUMIN TURNOVER IN NORMAL SUBJECTS AND PATIENTS WITH CIRRHOSIS MEASURED BY 131I-LABELLED HUMAN ALBUMIN.

Authors:  P WILKINSON; C L MENDENHALL
Journal:  Clin Sci       Date:  1963-10       Impact factor: 6.124

View more
  17 in total

Review 1.  Zinc and liver disease.

Authors:  Mohammad K Mohammad; Mohammad K Mohommad; Zhanxiang Zhou; Matthew Cave; Ashutosh Barve; Craig J McClain
Journal:  Nutr Clin Pract       Date:  2012-02       Impact factor: 3.080

2.  Appraisal of the methodology and applications for measurement of the zinc content of blood components as indicators of zinc status.

Authors:  J C Wallwork
Journal:  Biol Trace Elem Res       Date:  1987-04       Impact factor: 3.738

Review 3.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

4.  Zinc supplementation in experimental liver cirrhosis: a morphological, structural and ultrastructural study.

Authors:  E Gaudio; L Pannarale; A Franchitto; O Riggio
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

5.  Diurnal variations in serum and liver zinc levels throughout the 4-day estrous cycle of the hamster.

Authors:  T Shimada; E Hoshi; T Watanabe; A Endo
Journal:  Experientia       Date:  1980-08-15

6.  Albumin bound and alpha 2-macroglobulin bound zinc concentrations in the sera of healthy adults.

Authors:  J W Foote; H T Delves
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

7.  Zinc deficiency due to alcoholic cirrhosis mimicking acrodermatitis enteropathica.

Authors:  A Ilchyshyn; S Mendelsohn
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-05

8.  Another look at zinc.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

9.  Zinc and copper in multiple sclerosis.

Authors:  R Palm; G Hallmans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-08       Impact factor: 10.154

10.  Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis.

Authors:  L S Valberg; P R Flanagan; C N Ghent; M J Chamberlain
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.